Memorial Sloan Kettering Cancer Center Onco-Nephrology Symposium 2024

Memorial Sloan Kettering Cancer Center Onco-Nephrology Symposium 2024

$40.00

+ Include: 34 videos + 27 pdfs, size: 8.17 GB

+ Target Audience: nephrologists, physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease

Description

+ Include: 34 videos + 27 pdfs, size: 8.17 GB

+ Target Audience: nephrologists, physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease

+ Sample video: contact me for sample video

+ Information:

Date & Location: Friday, September 13, 2024, 8:00 AM – Saturday, September 14, 2024, 2:20 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Specialties – Bioethics, Cardiology, Critical Care, Endocrinology, Diabetes and Metabolism, General and Family Practice, Genitourinary Oncology, Hematology, Hospitalist, Internal Medicine, Medical Oncology, Molecular Pathology, Myeloma, Nephrology, Nurse Practitioner, Nursing, Oncology and Hematology, Pathology, Physician Assistant, Surgical Pathology, Urology
Overview

The 2024 Onco-Nephrology Symposium welcomes all members of the healthcare team who manage patients with both cancer and kidney disease. This year’s program embraces the multidisciplinary nature of onco-nephrology and features experts in plasma cell disorders such as multiple myeloma, amyloidosis, monoclonal gammopathies as well as renowned speakers on CAR T cell, other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes. The goal of this forum is to allow academicians, clinicians, and clinical experts to have personal exchanges and robust discussions in order to enhance the clinical experiences and outcomes of patients.

The target audience for this program includes physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease. This symposium offers attendees the option to participate either in person at Memorial Sloan Kettering’s Zuckerman Research Center (417 East 68th Street, New York City) or virtually via Zoom.

Objectives
At the conclusion of this symposium, attendees will be able to:
  1. Outline a comprehensive assessment and treatment of thrombotic microangiopathy
  2. Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
  3. Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
  4. Recognize renal and non-renal toxicities of modern cancer therapy
  5. Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
  6. Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
  7. Review assessment and management of glomerular disorders in cancer patients
  8. Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney

 

+ Topics:

Abstracts.pdf

An Update on Radiation Nephropathy – From EBRT to Therapeutic Isotopes.mp4

An Update on Radiation Nephropathy – From EBRT to Therapeutic Isotopes.pdf

Beyond the Kidneys Q&A and Panel Discussion.mp4

CAR T Alphabet Soup.mp4

CAR T Alphabet Soup.pdf

CAR T Cell Therapy Q&A and Panel Discussion I.mp4

CAR T Cell Therapy Q&A and Panel Discussion II.mp4

CAR T Therapy in Patients with MM and ESRD.mp4

CAR T Therapy in Patients with MM and ESRD.pdf

CARs and Solid Organ Transplant.mp4

CARs and Solid Organ Transplant.pdf

Case Discussions.mp4

Complement Studies and Interpreting Genetic Testing & Role of Eculizumab and Other Therapies in Non-TA-TMA.mp4

Complement Studies and Interpreting Genetic Testing & Role of Eculizumab and Other Therapies in Non-TA-TMA.pdf

Diagnosis, Management, and Prognosis of Cardiac Amyloidosis.mp4

Diagnosis, Management, and Prognosis of Cardiac Amyloidosis.pdf

Endocrine Toxicities From ICPI.mp4

Endocrine Toxicities From ICPI.pdf

Glomerular and Tubular Matters Q&A and Panel Discussion.mp4

Glomerular Diseases in Chronic GVHD.mp4

Glomerular Diseases in Chronic GVHD.pdf

How I Assess Treatment Response in Plasma Cell Disorders.mp4

How I Assess Treatment Response in Plasma Cell Disorders.pdf

How I Treat AL Amyloidosis with Kidney Involvement.mp4

How I Treat AL Amyloidosis with Kidney Involvement.pdf

How I Treat Monoclonal Gammopathy of Renal Significance (MGRS).mp4

How I Treat Monoclonal Gammopathy of Renal Significance (MGRS).pdf

How I Treat Multiple Myeloma.mp4

How I Treat Multiple Myeloma.pdf

How I Use Serum Free Light Chains in Clinical Practice.mp4

How I Use Serum Free Light Chains in Clinical Practice.pdf

Let’s Go to the Data- Eculizumab, Narsoplimab in TA-TMA.mp4

Let’s Go to the Data- Eculizumab, Narsoplimab in TA-TMA.pdf

Management of BK Nephropathy Post-SCT.mp4

Management of BK Nephropathy Post-SCT.pdf

Mass Spectrometry Made Simple.mp4

Mass Spectrometry Made Simple.pdf

Modern Approach to the Diagnosis and Treatment of Renal Cancer.mp4

Modern Approach to the Diagnosis and Treatment of Renal Cancer.pdf

Modern Approach to the Diagnosis and Treatment of Small Renal Masses.mp4

Modern Approach to the Diagnosis and Treatment of Small Renal Masses.pdf

Modern Approach to the Diagnosis and Treatment of Testicular Cancer.mp4

Modern Approach to the Diagnosis and Treatment of Testicular Cancer.pdf

Monoclonal Proteins Getting to the Heart of the Matter Q&A and Panel Discussion.mp4

Newer Methodologies to Detect Monoclonal Proteins in the Blood and Urine in Monoclonal Gammopathy of Renal Significance (MGRS).mp4

Newer Methodologies to Detect Monoclonal Proteins in the Blood and Urine in Monoclonal Gammopathy of Renal Significance (MGRS).pdf

Newer Methodologies to Detect Monoclonal Proteins on the Kidney Biopsy.mp4

Newer Methodologies to Detect Monoclonal Proteins on the Kidney Biopsy.pdf

Next Generation Therapy- CARTs and Beyond.mp4

Next Generation Therapy- CARTs and Beyond.pdf

OncoNeph2024_Brochure.pdf

Renal and Testicular Cancer Q&A and Panel Discussion.mp4

This is How We Do It Q&A and Panel Discussion.mp4

Thrombotic Microangiopathy Q&A and Panel Discussion.mp4

TMA- Demystifying the Complement Pathway.mp4

TMA- Demystifying the Complement Pathway.pdf

Updates in the Management of Cancer Treatment-Related Cardiac Toxicities.mp4

Updates in the Management of Cancer Treatment-Related Cardiac Toxicities.pdf

VEGF Inhibitors and TKIs- Stopping and Restarting After Kidney Injury.mp4

VEGF Inhibitors and TKIs- Stopping and Restarting After Kidney Injury.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center Onco-Nephrology Symposium 2024”

Your email address will not be published. Required fields are marked *

Related Products